JWEL — Jamieson Wellness Cashflow Statement
0.000.00%
- CA$1.44bn
- CA$1.86bn
- CA$733.78m
- 93
- 60
- 78
- 92
Annual cashflow statement for Jamieson Wellness, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 41.6 | 52.1 | 52.8 | 46 | 51.1 |
| Depreciation | |||||
| Amortisation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 5.05 | 5.85 | 5.88 | -4.29 | 18.8 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -20.2 | -27.3 | -27 | -32.1 | -31.2 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | 40.6 | 44.4 | 50.6 | 31.7 | 61.6 |
| Capital Expenditures | -11.3 | -21.5 | -13.9 | -8.84 | -9.18 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -1.92 | -0.786 | -243 | -26.3 | -0.983 |
| Acquisition of Business | |||||
| Change in Net Intangibles | |||||
| Cash from Investing Activities | -13.2 | -22.3 | -257 | -35.1 | -10.2 |
| Financing Cash Flow Items | — | — | — | 44.4 | 0 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -26.5 | -16.5 | 225 | 14 | -45.4 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.968 | 5.61 | 19.5 | 10.6 | 7.92 |